AMERICAN ORIENTL BIO (NYSE:AOBID)

CAPS Rating: 2 out of 5

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

Recs

0
Player Avatar AllYouCanEatBuff (< 20) Submitted: 3/28/2011 11:51:52 AM : Outperform Start Price: $3.24 AOBID Score: -150.16

At this price, stock is way undervalued. They have some of the best recognized medical brands in China. However, they lack pricing power due to new govt reforms, and have shown that they have trouble allocating capital (constructing an expensive headquarters that decreased margins significantly). Despite this, strong brand in a growing economy and a booming middle class with disposable income = profitable company.

Featured Broker Partners


Advertisement